6 Patents
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US117393262023RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition
The Schepens Eye Research Institute, Inc.
0 cites
The Schepens Eye Research Institute, Inc.